Sponsored Article

Published in:
Volume 12 / Year 2023 / Issue 3

Biosimilar antibody drug conjugates: considerations of higher order structure and aggregation

Author(s):

Abstract: Undoubtedly the complexity of antibody drug conjugate (ADC) molecules where three components (monoclonal antibody, cytotoxic drug and appropriate linker) are involved poses a challenge for biosimilar development. As with… Read More »

Go Back Print